 |
|
The Proportion of Rifabutin-susceptible Strains among Rifampicin- resistant Isolates and Its Specific rpoB Mutations.
Woo Jin Lew, Young Kil Park, Hee Jin Kim, Chulhun Chang, Gill Han Bai, Sung Kyu Kim
Tuberc Respir Dis. 2005;59(3):257-265. Published online 2005 Sep 1 DOI: https://doi.org/10.4046/trd.2005.59.3.257
|
|
Citations to this article as recorded by
 Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea
Se-Mi Jeon, Sanghee Park, Na-Ra Lim, Noori Lee, Jihee Jung, Nackmoon Sung, Seonghan Kim
Antibiotics.2023; 12(8): 1324. CrossRef Critical Review
H. Manisha Yapa, Marta Boffito, Anton Pozniak
JAIDS Journal of Acquired Immune Deficiency Syndromes.2016; 72(2): 138. CrossRef Diagnosis and Treatment of Multidrug-Resistant Tuberculosis
Tae Sun Shim
Korean Journal of Medicine.2015; 88(5): 509. CrossRef The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis
Kyung-Wook Jo, Wonjun Ji, Yoonki Hong, Sang-Do Lee, Woo Sung Kim, Dong Soon Kim, Tae Sun Shim
Respiratory Medicine.2013; 107(2): 292. CrossRef Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis
Tae Sun Shim, Kyung-Wook Jo
Infection & Chemotherapy.2013; 45(4): 367. CrossRef The Up-to-date of Anti-Tuberculosis Treatment
Woo-Jin Lew
Tuberculosis and Respiratory Diseases.2006; 60(3): 270. CrossRef Cross-resistance Between Rifampicin and Rifabutin and Its Relationship with rpoB Gene Mutations in Clinically Isolated MDR-TB Strains
Byoung Ju Kim, Seung Hwan Oh, Eun Jin Cho, Seung Kyu Park
Tuberculosis and Respiratory Diseases.2006; 60(2): 171. CrossRef
|